Current advances in the elimination of hepatitis B in China by 2030
chronic hepatitis B、human immunodeficiency virus、hepatotropic viruses、treatment outcomes、HBV replication、liver diseases、public health、prevention of
11
R5 ;R51
This review was funded by the Major State Basic Research Development Program2015CB554300 to SZ;the National Natural Science Foundation of China No.91442127 to ZZ.The authors also thank Ms.Jingjing Yan at the Shanghai Public Health Clinical Center for her assistance in preparing the figure
2018-01-26(万方平台首次上网日期,不代表论文的发表时间)
共12页
490-501